754.4K XNAS Volume
XNAS 04 Apr, 2025 5:30 PM (EDT)
Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.95 per share. | 12 Mar 2025 | 26,591 | 286,588 (0%) | 0% | 1.9 | 51,852 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2025 | 26,591 | 26,592 | - | - | Stock Option (Right to Buy) | |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2025 | 26,592 | 0 | - | - | Stock Option (Right to Buy) | |
Dominick C. Colangelo | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 45.78 per share. | 12 Mar 2025 | 26,592 | 259,997 (0%) | 0% | 45.8 | 1,217,382 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.95 per share. | 12 Mar 2025 | 26,592 | 286,589 (0%) | 0% | 1.9 | 51,854 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 46.31 per share. | 12 Mar 2025 | 26,591 | 259,997 (0%) | 0% | 46.3 | 1,231,429 | Common Stock |
Heidi M. Hagen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.74 per share. | 03 Mar 2025 | 9,000 | 37,650 (0%) | 0% | 3.7 | 33,660 | Common Stock |
Heidi M. Hagen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 9,000 | 0 | - | - | Stock Option (Right to Buy) | |
Heidi M. Hagen | Director | Sale of securities on an exchange or to another person at price $ 49.53 per share. | 03 Mar 2025 | 9,000 | 28,650 (0%) | 0% | 49.5 | 445,770 | Common Stock |
Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 10,000 | 28,750 | - | - | Stock Option (Right to Buy) | |
Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.00 per share. | 03 Mar 2025 | 10,000 | 76,101 (0%) | 0% | 18 | 180,000 | Common Stock |
Jonathan Mark Hopper | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 49.53 per share. | 03 Mar 2025 | 10,000 | 66,101 (0%) | 0% | 49.5 | 495,300 | Common Stock |
Michael Halpin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 49.52 per share. | 03 Mar 2025 | 10,000 | 15,539 (0%) | 0% | 49.5 | 495,200 | Common Stock |
Michael Halpin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 10,000 | 66,250 | - | - | Stock Option (Right to Buy) | |
Michael Halpin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.66 per share. | 03 Mar 2025 | 10,000 | 25,359 (0%) | 0% | 16.7 | 166,600 | Common Stock |
Joseph A. Mara | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 49.53 per share. | 03 Mar 2025 | 9,000 | 13,967 (0%) | 0% | 49.5 | 445,770 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2025 | 18,250 | 54,750 | - | - | Restricted Stock Unit | |
Dominick C. Colangelo | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.33 per share. | 24 Feb 2025 | 8,459 | 259,997 (0%) | 0% | 52.3 | 442,659 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2025 | 18,250 | 268,456 (0%) | 0% | 0 | Common Stock | |
Jonathan Mark Hopper | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.33 per share. | 24 Feb 2025 | 636 | 66,101 (0%) | 0% | 52.3 | 33,282 | Common Stock |
Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2025 | 1,500 | 9,000 | - | - | Restricted Stock Unit | |
Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2025 | 1,500 | 10,500 | - | - | Restricted Stock Unit | |
Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2025 | 1,500 | 66,737 (0%) | 0% | 0 | Common Stock | |
Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2025 | 1,500 | 65,237 (0%) | 0% | - | Common Stock | |
Michael Halpin | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.33 per share. | 24 Feb 2025 | 2,486 | 15,539 (0%) | 0% | 52.3 | 130,092 | Common Stock |
Michael Halpin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2025 | 5,250 | 18,025 (0%) | 0% | 0 | Common Stock | |
Michael Halpin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2025 | 5,250 | 15,750 | - | - | Restricted Stock Unit | |
Sean C. Flynn | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 52.07 per share. | 24 Feb 2025 | 1,669 | 756 (0%) | 0% | 52.1 | 86,905 | Common Stock |
Sean C. Flynn | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2025 | 3,000 | 9,000 | - | - | Restricted Stock Unit | |
Sean C. Flynn | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.33 per share. | 24 Feb 2025 | 1,331 | 2,425 (0%) | 0% | 52.3 | 69,651 | Common Stock |
Sean C. Flynn | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2025 | 3,000 | 3,756 (0%) | 0% | 0 | Common Stock | |
Joseph A. Mara | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2025 | 4,625 | 24,325 (0%) | 0% | 0 | Common Stock | |
Joseph A. Mara | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.33 per share. | 24 Feb 2025 | 1,358 | 22,967 (0%) | 0% | 52.3 | 71,064 | Common Stock |
Joseph A. Mara | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2025 | 4,625 | 13,875 | - | - | Restricted Stock Unit | |
D. | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 52.07 per share. | 24 Feb 2025 | 1,137 | 1,206 (0%) | 0% | 52.1 | 59,204 | Common Stock |
D. | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2025 | 1,875 | 3,081 (0%) | 0% | 0 | Common Stock | |
D. | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2025 | 1,875 | 5,625 | - | - | Restricted Stock Unit | |
D. | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.33 per share. | 24 Feb 2025 | 738 | 2,343 (0%) | 0% | 52.3 | 38,620 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 73,000 | 73,000 | - | - | Restricted Stock Unit | |
Dominick C. Colangelo | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 182,500 | 182,500 | - | - | Stock Option (Right to Buy) | |
Jonathan Mark Hopper | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
Jonathan Mark Hopper | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 14,000 | 14,000 | - | - | Restricted Stock Unit | |
Michael Halpin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 21,000 | 21,000 | - | - | Restricted Stock Unit | |
Michael Halpin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 52,500 | 52,500 | - | - | Stock Option (Right to Buy) | |
Sean C. Flynn | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 14,000 | 14,000 | - | - | Restricted Stock Unit | |
Sean C. Flynn | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
Sean C. Flynn | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 57.32 per share. | 20 Feb 2025 | 3,835 | 756 (0%) | 0% | 57.3 | 219,822 | Common Stock |
Joseph A. Mara | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 46,250 | 46,250 | - | - | Stock Option (Right to Buy) | |
Joseph A. Mara | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 18,500 | 18,500 | - | - | Restricted Stock Unit | |
D. | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 6,600 | 6,600 | - | - | Stock Option (Right to Buy) | |
D. | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 6,160 | 6,160 | - | - | Restricted Stock Unit | |
Karen Mahoney | Chief Human Resources Officer | 20 Feb 2025 | 12,938 | 12,938 | - | - | Stock Option (Right to Buy) | ||
Dominick C. Colangelo | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.78 per share. | 18 Feb 2025 | 4,196 | 250,206 (0%) | 0% | 57.8 | 242,445 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 8,938 | 254,402 (0%) | 0% | 0 | Common Stock | |
Dominick C. Colangelo | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.28 per share. | 18 Feb 2025 | 5,423 | 245,464 (0%) | 0% | 57.3 | 310,629 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 11,700 | 250,887 (0%) | 0% | 0 | Common Stock | |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 18,250 | 239,187 (0%) | 0% | - | Common Stock | |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 11,700 | 11,700 | - | - | Restricted Stock Unit | |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 18,250 | 36,500 | - | - | Restricted Stock Unit | |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 8,938 | 0 | - | - | Restricted Stock Unit | |
Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 2,325 | 2,325 | - | - | Restricted Stock Unit | |
Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 3,000 | 6,000 | - | - | Restricted Stock Unit | |
Jonathan Mark Hopper | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.78 per share. | 18 Feb 2025 | 853 | 63,737 (0%) | 0% | 57.8 | 49,286 | Common Stock |
Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 1,750 | 64,590 (0%) | 0% | 0 | Common Stock | |
Jonathan Mark Hopper | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.28 per share. | 18 Feb 2025 | 985 | 62,840 (0%) | 0% | 57.3 | 56,421 | Common Stock |
Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 2,325 | 63,825 (0%) | 0% | 0 | Common Stock | |
Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 3,000 | 61,500 (0%) | 0% | - | Common Stock | |
Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 1,750 | 0 | - | - | Restricted Stock Unit | |
Michael Halpin | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.78 per share. | 18 Feb 2025 | 1,332 | 12,775 (0%) | 0% | 57.8 | 76,963 | Common Stock |
Michael Halpin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 2,813 | 0 | - | - | Restricted Stock Unit | |
Michael Halpin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 3,825 | 3,825 | - | - | Restricted Stock Unit | |
Michael Halpin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 5,250 | 11,858 (0%) | 0% | 0 | Common Stock | |
Michael Halpin | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.28 per share. | 18 Feb 2025 | 2,577 | 9,281 (0%) | 0% | 57.3 | 147,611 | Common Stock |
Michael Halpin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 3,825 | 13,106 (0%) | 0% | 0 | Common Stock | |
Michael Halpin | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.28 per share. | 18 Feb 2025 | 1,812 | 11,294 (0%) | 0% | 57.3 | 103,791 | Common Stock |
Michael Halpin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 2,813 | 14,107 (0%) | 0% | 0 | Common Stock | |
Michael Halpin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 5,250 | 10,500 | - | - | Restricted Stock Unit | |
Sean C. Flynn | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 3,000 | 6,000 | - | - | Restricted Stock Unit | |
Sean C. Flynn | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 2,325 | 2,325 | - | - | Restricted Stock Unit | |
Sean C. Flynn | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 1,750 | 0 | - | - | Restricted Stock Unit | |
Sean C. Flynn | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 3,000 | 3,756 (0%) | 0% | 0 | Common Stock | |
Sean C. Flynn | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.28 per share. | 18 Feb 2025 | 1,431 | 2,325 (0%) | 0% | 57.3 | 81,968 | Common Stock |
Sean C. Flynn | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 2,325 | 4,650 (0%) | 0% | 0 | Common Stock | |
Sean C. Flynn | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.28 per share. | 18 Feb 2025 | 1,032 | 3,618 (0%) | 0% | 57.3 | 59,113 | Common Stock |
Sean C. Flynn | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 1,750 | 5,368 (0%) | 0% | 0 | Common Stock | |
Sean C. Flynn | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.78 per share. | 18 Feb 2025 | 777 | 4,591 (0%) | 0% | 57.8 | 44,895 | Common Stock |
Joseph A. Mara | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 2,754 | 2,755 | - | - | Restricted Stock Unit | |
Joseph A. Mara | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 4,625 | 19,205 (0%) | 0% | 0 | Common Stock | |
Joseph A. Mara | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.28 per share. | 18 Feb 2025 | 1,450 | 17,755 (0%) | 0% | 57.3 | 83,056 | Common Stock |
Joseph A. Mara | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 2,754 | 20,509 (0%) | 0% | 0 | Common Stock | |
Joseph A. Mara | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.28 per share. | 18 Feb 2025 | 809 | 19,700 (0%) | 0% | 57.3 | 46,340 | Common Stock |
Joseph A. Mara | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 4,625 | 9,250 | - | - | Restricted Stock Unit | |
D. | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 420 | 3,082 (0%) | 0% | 0 | Common Stock | |
D. | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 420 | 420 | - | - | Restricted Stock Unit | |
D. | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 2,500 | 5,000 | - | - | Restricted Stock Unit | |
D. | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 56.72 per share. | 18 Feb 2025 | 1,710 | 1,206 (0%) | 0% | 56.7 | 96,991 | Common Stock |
D. | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.28 per share. | 18 Feb 2025 | 166 | 2,916 (0%) | 0% | 57.3 | 9,508 | Common Stock |
D. | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 2,500 | 3,706 (0%) | 0% | 0 | Common Stock | |
D. | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.28 per share. | 18 Feb 2025 | 1,044 | 2,662 (0%) | 0% | 57.3 | 59,800 | Common Stock |
Kevin F. Mclaughlin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.74 per share. | 12 Feb 2025 | 6,000 | 17,900 (0%) | 0% | 3.7 | 22,440 | Common Stock |
Kevin F. Mclaughlin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 1,000 | 14,000 | - | - | Stock Option (Right to Buy) | |
Kevin F. Mclaughlin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 6,000 | 0 | - | - | Stock Option (Right to Buy) | |
Kevin F. Mclaughlin | Director | Sale of securities on an exchange or to another person at price $ 55.43 per share. | 12 Feb 2025 | 1,000 | 11,900 (0%) | 0% | 55.4 | 55,430 | Common Stock |
Kevin F. Mclaughlin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.76 per share. | 12 Feb 2025 | 1,000 | 12,900 (0%) | 0% | 2.8 | 2,760 | Common Stock |
Kevin F. Mclaughlin | Director | Sale of securities on an exchange or to another person at price $ 55.47 per share. | 12 Feb 2025 | 6,000 | 11,900 (0%) | 0% | 55.5 | 332,820 | Common Stock |
Alan L. Rubino | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.74 per share. | 07 Feb 2025 | 4,000 | 27,794 (0%) | 0% | 3.7 | 14,960 | Common Stock |
Alan L. Rubino | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2025 | 15,000 | 0 | - | - | Stock Option (Right to Buy) | |
Alan L. Rubino | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2025 | 4,000 | 0 | - | - | Stock Option (Right to Buy) | |
Alan L. Rubino | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.74 per share. | 07 Feb 2025 | 15,000 | 42,794 (0%) | 0% | 3.7 | 56,100 | Common Stock |
Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2025 | 2,500 | 7,500 | - | - | Stock Option (Right to Buy) | |
Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.05 per share. | 05 Feb 2025 | 2,500 | 29,095 (0%) | 0% | 13.1 | 32,625 | Common Stock |
Robert L. Zerbe | Director | Sale of securities on an exchange or to another person at price $ 62.50 per share. | 05 Feb 2025 | 2,500 | 26,595 (0%) | 0% | 62.5 | 156,250 | Common Stock |
D. | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 61.99 per share. | 05 Feb 2025 | 1,092 | 1,206 (0%) | 0% | 62.0 | 67,693 | Common Stock |
D. | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 48.80 per share. | 05 Feb 2025 | 1,092 | 2,298 (0%) | 0% | 48.8 | 53,290 | Common Stock |
D. | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2025 | 1,092 | 51,875 | - | - | Stock Option (Right to Buy) | |
D. | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 48.80 per share. | 28 Jan 2025 | 3,908 | 5,114 (0%) | 0% | 48.8 | 190,710 | Common Stock |
D. | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 61.99 per share. | 28 Jan 2025 | 3,908 | 1,206 (0%) | 0% | 62.0 | 242,257 | Common Stock |
D. | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2025 | 3,908 | 52,967 | - | - | Stock Option (Right to Buy) | |
Jonathan Mark Hopper | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 34.04 per share. | 31 Dec 2024 | 129 | 58,500 (0%) | 0% | 34.0 | 4,391 | Common Stock |
Michael Halpin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 34.04 per share. | 31 Dec 2024 | 109 | 6,608 (0%) | 0% | 34.0 | 3,710 | Common Stock |
Michael Halpin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 35.91 per share. | 31 Dec 2024 | 120 | 6,499 (0%) | 0% | 35.9 | 4,309 | Common Stock |
Michael Halpin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 39.00 per share. | 31 Dec 2024 | 95 | 6,379 (0%) | 0% | 39 | 3,705 | Common Stock |
Sean C. Flynn | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 35.92 per share. | 31 Dec 2024 | 49 | 756 (0%) | 0% | 35.9 | 1,760 | Common Stock |
Joseph A. Mara | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 35.91 per share. | 31 Dec 2024 | 76 | 14,511 (0%) | 0% | 35.9 | 2,729 | Common Stock |
Joseph A. Mara | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 34.04 per share. | 31 Dec 2024 | 68 | 14,580 (0%) | 0% | 34.0 | 2,315 | Common Stock |
K. Wotton Paul | Director | Sale of securities on an exchange or to another person at price $ 58.72 per share. | 04 Dec 2024 | 2,600 | 27,402 (0%) | 0% | 58.7 | 152,672 | Common Stock |
Hopper Jonathan Mark | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.66 per share. | 02 Dec 2024 | 10,000 | 68,371 (0%) | 0% | 16.7 | 166,600 | Common Stock |
Mark Jonathan Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 10,000 | 6,000 | - | - | Stock Option (Right to Buy) | |
Jonathan Mark Hopper | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 58.72 per share. | 02 Dec 2024 | 10,000 | 58,371 (0%) | 0% | 58.7 | 587,200 | Common Stock |
Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.05 per share. | 22 Nov 2024 | 2,500 | 29,095 (0%) | 0% | 13.1 | 32,625 | Common Stock |
Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Nov 2024 | 2,500 | 10,000 | - | - | Stock Option (Right to Buy) | |
Robert L. Zerbe | Director | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 22 Nov 2024 | 2,500 | 26,595 (0%) | 0% | 60 | 150,000 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.02 per share. | 13 Nov 2024 | 17,500 | 238,437 (0%) | 0% | 3.0 | 52,850 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Nov 2024 | 17,500 | 0 | - | - | Stock Option (Right to Buy) | |
Dominick C. Colangelo | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 53.93 per share. | 13 Nov 2024 | 17,500 | 220,937 (0%) | 0% | 53.9 | 943,775 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Nov 2024 | 17,500 | 17,500 | - | - | Stock Option (Right to Buy) | |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.02 per share. | 13 Nov 2024 | 17,500 | 238,437 (0%) | 0% | 3.0 | 52,850 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 55.57 per share. | 13 Nov 2024 | 17,500 | 220,937 (0%) | 0% | 55.6 | 972,475 | Common Stock |
Kevin F. Mclaughlin | Director | Sale of securities on an exchange or to another person at price $ 55.54 per share. | 13 Nov 2024 | 7,000 | 11,900 (0%) | 0% | 55.5 | 388,780 | Common Stock |
Kevin F. Mclaughlin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Nov 2024 | 7,000 | 6,000 | - | - | Stock Option (Right to Buy) | |
Kevin F. Mclaughlin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.74 per share. | 13 Nov 2024 | 7,000 | 18,900 (0%) | 0% | 3.7 | 26,180 | Common Stock |
Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.05 per share. | 11 Nov 2024 | 2,500 | 29,095 (0%) | 0% | 13.1 | 32,625 | Common Stock |
Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2024 | 2,500 | 15,000 | - | - | Stock Option (Right to Buy) | |
Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2024 | 2,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
Robert L. Zerbe | Director | Sale of securities on an exchange or to another person at price $ 57.50 per share. | 11 Nov 2024 | 2,500 | 26,595 (0%) | 0% | 57.5 | 143,750 | Common Stock |
Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.05 per share. | 11 Nov 2024 | 2,500 | 29,095 (0%) | 0% | 13.1 | 32,625 | Common Stock |
Robert L. Zerbe | Director | Sale of securities on an exchange or to another person at price $ 55.00 per share. | 11 Nov 2024 | 2,500 | 26,595 (0%) | 0% | 55 | 137,500 | Common Stock |
Heidi M. Hagen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.74 per share. | 17 Oct 2024 | 6,000 | 28,650 (0%) | 0% | 3.7 | 22,440 | Common Stock |
Heidi M. Hagen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Oct 2024 | 4,000 | 0 | - | - | Stock Option (Right to Buy) | |
Heidi M. Hagen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Oct 2024 | 6,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
Heidi M. Hagen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.74 per share. | 17 Oct 2024 | 4,000 | 22,650 (0%) | 0% | 3.7 | 14,960 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.02 per share. | 16 Oct 2024 | 17,500 | 238,437 (0%) | 0% | 3.0 | 52,850 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.02 per share. | 16 Oct 2024 | 17,500 | 238,437 (0%) | 0% | 3.0 | 52,850 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 41.38 per share. | 16 Oct 2024 | 17,500 | 220,937 (0%) | 0% | 41.4 | 724,150 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Oct 2024 | 17,500 | 35,000 | - | - | Stock Option (Right to Buy) | |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Oct 2024 | 17,500 | 52,500 | - | - | Stock Option (Right to Buy) | |
Dominick C. Colangelo | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 40.34 per share. | 16 Oct 2024 | 17,500 | 220,937 (0%) | 0% | 40.3 | 705,950 | Common Stock |
Steven C. Gilman | Director | Sale of securities on an exchange or to another person at price $ 41.36 per share. | 16 Oct 2024 | 5,833 | 11,000 (0%) | 0% | 41.4 | 241,253 | Common Stock |
Steven C. Gilman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Oct 2024 | 5,833 | 0 | - | - | Stock Option (Right to Buy) | |
Steven C. Gilman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.05 per share. | 16 Oct 2024 | 5,833 | 16,833 (0%) | 0% | 13.1 | 76,121 | Common Stock |
Steven C. Gilman | Director | Sale of securities on an exchange or to another person at price $ 40.35 per share. | 02 Oct 2024 | 5,833 | 11,000 (0%) | 0% | 40.4 | 235,362 | Common Stock |
Steven C. Gilman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.05 per share. | 02 Oct 2024 | 5,833 | 16,833 (0%) | 0% | 13.1 | 76,121 | Common Stock |
Steven C. Gilman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Oct 2024 | 5,833 | 5,833 | - | - | Stock Option (Right to Buy) | |
Jonathan Siegal | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2024 | 937 | 938 | - | - | Restricted Stock Unit | |
Jonathan Siegal | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 41.90 per share. | 30 Sep 2024 | 568 | 1,124 (0%) | 0% | 41.9 | 23,799 | Common Stock |
Jonathan Siegal | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.25 per share. | 30 Sep 2024 | 369 | 1,692 (0%) | 0% | 42.2 | 15,590 | Common Stock |
Jonathan Siegal | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2024 | 937 | 2,061 (0%) | 0% | 0 | Common Stock | |
Steven C. Gilman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.05 per share. | 18 Sep 2024 | 5,834 | 16,834 (0%) | 0% | 13.1 | 76,134 | Common Stock |
Steven C. Gilman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Sep 2024 | 5,834 | 11,666 | - | - | Stock Option (Right to Buy) | |
Steven C. Gilman | Director | Sale of securities on an exchange or to another person at price $ 45.54 per share. | 18 Sep 2024 | 5,834 | 11,000 (0%) | 0% | 45.5 | 265,680 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.02 per share. | 11 Sep 2024 | 17,500 | 238,437 (0%) | 0% | 3.0 | 52,850 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2024 | 17,500 | 70,000 | - | - | Stock Option (Right to Buy) | |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2024 | 17,500 | 87,500 | - | - | Stock Option (Right to Buy) | |
Dominick C. Colangelo | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 43.90 per share. | 11 Sep 2024 | 17,500 | 220,937 (0%) | 0% | 43.9 | 768,250 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.02 per share. | 11 Sep 2024 | 17,500 | 238,437 (0%) | 0% | 3.0 | 52,850 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 43.37 per share. | 11 Sep 2024 | 17,500 | 220,937 (0%) | 0% | 43.4 | 758,975 | Common Stock |
Steven C. Gilman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Sep 2024 | 5,000 | 0 | - | - | Stock Option (Right to Buy) | |
Steven C. Gilman | Director | Sale of securities on an exchange or to another person at price $ 48.58 per share. | 04 Sep 2024 | 5,000 | 11,000 (0%) | 0% | 48.6 | 242,900 | Common Stock |
Steven C. Gilman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.74 per share. | 04 Sep 2024 | 5,000 | 16,000 (0%) | 0% | 3.7 | 18,700 | Common Stock |
Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.95 per share. | 03 Sep 2024 | 10,000 | 68,229 (0%) | 0% | 11.0 | 109,500 | Common Stock |
Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2024 | 10,000 | 12,604 | - | - | Stock Option (Right to Buy) | |
Jonathan Mark Hopper | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 49.83 per share. | 03 Sep 2024 | 10,000 | 58,229 (0%) | 0% | 49.8 | 498,300 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.02 per share. | 14 Aug 2024 | 17,500 | 238,437 (0%) | 0% | 3.0 | 52,850 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.02 per share. | 14 Aug 2024 | 17,500 | 238,437 (0%) | 0% | 3.0 | 52,850 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 46.24 per share. | 14 Aug 2024 | 17,500 | 220,937 (0%) | 0% | 46.2 | 809,200 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2024 | 17,500 | 122,500 | - | - | Stock Option (Right to Buy) | |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2024 | 17,500 | 105,000 | - | - | Stock Option (Right to Buy) | |
Dominick C. Colangelo | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 45.17 per share. | 14 Aug 2024 | 17,500 | 220,937 (0%) | 0% | 45.2 | 790,475 | Common Stock |
Kevin F. Mclaughlin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.74 per share. | 07 Aug 2024 | 5,000 | 16,900 (0%) | 0% | 3.7 | 18,700 | Common Stock |
Kevin F. Mclaughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2024 | 2,000 | 13,000 | - | - | Stock Option (Right to Buy) | |
Kevin F. Mclaughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2024 | 5,000 | 0 | - | - | Stock Option (Right to Buy) | |
Kevin F. Mclaughlin | Director | Sale of securities on an exchange or to another person at price $ 45.99 per share. | 07 Aug 2024 | 2,000 | 11,900 (0%) | 0% | 46.0 | 91,980 | Common Stock |
Kevin F. Mclaughlin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.74 per share. | 07 Aug 2024 | 2,000 | 13,900 (0%) | 0% | 3.7 | 7,480 | Common Stock |
Kevin F. Mclaughlin | Director | Sale of securities on an exchange or to another person at price $ 45.92 per share. | 07 Aug 2024 | 5,000 | 11,900 (0%) | 0% | 45.9 | 229,600 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.02 per share. | 17 Jul 2024 | 17,500 | 238,437 (0%) | 0% | 3.0 | 52,850 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 51.40 per share. | 17 Jul 2024 | 17,500 | 220,937 (0%) | 0% | 51.4 | 899,500 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 17,500 | 157,500 | - | - | Stock Option (Right to Buy) | |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 17,500 | 140,000 | - | - | Stock Option (Right to Buy) | |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.02 per share. | 17 Jul 2024 | 17,500 | 238,437 (0%) | 0% | 3.0 | 52,850 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 51.55 per share. | 17 Jul 2024 | 17,500 | 220,937 (0%) | 0% | 51.6 | 902,125 | Common Stock |
Sean C. Flynn | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 52.18 per share. | 16 Jul 2024 | 15,000 | 707 (0%) | 0% | 52.2 | 782,700 | Common Stock |
Sean C. Flynn | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2024 | 15,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
Sean C. Flynn | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.25 per share. | 16 Jul 2024 | 15,000 | 15,707 (0%) | 0% | 16.3 | 243,750 | Common Stock |
Joseph A. Mara | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 12 Jul 2024 | 5,000 | 14,436 (0%) | 0% | 50 | 250,000 | Common Stock |
Jonathan Siegal | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 45.00 per share. | 05 Jul 2024 | 545 | 1,033 (0%) | 0% | 45 | 24,525 | Common Stock |
Sean C. Flynn | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.25 per share. | 20 Jun 2024 | 6,754 | 7,241 (0%) | 0% | 16.3 | 109,753 | Common Stock |
Sean C. Flynn | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2024 | 6,772 | 116,474 | - | - | Stock Option (Right to Buy) | |
Sean C. Flynn | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2024 | 1,474 | 115,000 | - | - | Stock Option (Right to Buy) | |
Sean C. Flynn | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2024 | 6,754 | 123,246 | - | - | Stock Option (Right to Buy) | |
Sean C. Flynn | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 45.84 per share. | 20 Jun 2024 | 1,474 | 487 (0%) | 0% | 45.8 | 67,568 | Common Stock |
Sean C. Flynn | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.25 per share. | 20 Jun 2024 | 1,474 | 1,961 (0%) | 0% | 16.3 | 23,953 | Common Stock |
Sean C. Flynn | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 45.02 per share. | 20 Jun 2024 | 6,772 | 487 (0%) | 0% | 45.0 | 304,875 | Common Stock |
Sean C. Flynn | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.25 per share. | 20 Jun 2024 | 6,772 | 7,259 (0%) | 0% | 16.3 | 110,045 | Common Stock |
Sean C. Flynn | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 45.04 per share. | 20 Jun 2024 | 6,754 | 487 (0%) | 0% | 45.0 | 304,200 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.02 per share. | 12 Jun 2024 | 17,500 | 238,252 (0%) | 0% | 3.0 | 52,850 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2024 | 17,500 | 175,000 | - | - | Stock Option (Right to Buy) | |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2024 | 17,500 | 192,500 | - | - | Stock Option (Right to Buy) | |
Dominick C. Colangelo | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 43.10 per share. | 12 Jun 2024 | 17,500 | 220,752 (0%) | 0% | 43.1 | 754,250 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.02 per share. | 12 Jun 2024 | 17,500 | 238,252 (0%) | 0% | 3.0 | 52,850 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 44.12 per share. | 12 Jun 2024 | 17,500 | 220,752 (0%) | 0% | 44.1 | 772,100 | Common Stock |
Lisa Wright | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 434 | 0 | - | - | Restricted Stock Unit | |
Lisa Wright | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 434 | 9,451 (0%) | 0% | - | Common Stock | |
Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 10,000 | 22,604 | - | - | Stock Option (Right to Buy) | |
Jonathan Mark Hopper | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 49.99 per share. | 20 May 2024 | 10,000 | 58,116 (0%) | 0% | 50.0 | 499,900 | Common Stock |
Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.95 per share. | 20 May 2024 | 10,000 | 68,116 (0%) | 0% | 11.0 | 109,500 | Common Stock |
Michael Halpin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2024 | 3,132 | 0 | - | - | Stock Option (Right to Buy) | |
Michael Halpin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.20 per share. | 17 May 2024 | 3,132 | 6,284 (0%) | 0% | 7.2 | 22,550 | Common Stock |
Michael Halpin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.65 per share. | 17 May 2024 | 2,063 | 3,152 (0%) | 0% | 2.7 | 5,467 | Common Stock |
Michael Halpin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2024 | 2,063 | 0 | - | - | Stock Option (Right to Buy) | |
Dominick C. Colangelo | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 47.85 per share. | 15 May 2024 | 17,500 | 220,752 (0%) | 0% | 47.9 | 837,375 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 17,500 | 227,500 | - | - | Stock Option (Right to Buy) | |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 17,500 | 210,000 | - | - | Stock Option (Right to Buy) | |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.02 per share. | 15 May 2024 | 17,500 | 238,252 (0%) | 0% | 3.0 | 52,850 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 49.67 per share. | 15 May 2024 | 17,500 | 220,752 (0%) | 0% | 49.7 | 869,225 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.02 per share. | 15 May 2024 | 17,500 | 238,252 (0%) | 0% | 3.0 | 52,850 | Common Stock |
Paul K. Wotton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 3,200 | 30,002 (0%) | 0% | - | Common Stock | |
Paul K. Wotton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 3,200 | 3,200 | - | - | Restricted Stock Unit | |
Paul K. Wotton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 8,000 | 8,000 | - | - | Stock Option (Right to Buy) | |
Paul K. Wotton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 3,200 | 0 | - | - | Restricted Stock Unit | |
Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 3,200 | 26,595 (0%) | 0% | - | Common Stock | |
Robert L. Zerbe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 3,200 | 3,200 | - | - | Restricted Stock Unit | |
Robert L. Zerbe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 8,000 | 8,000 | - | - | Stock Option (Right to Buy) | |
Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 3,200 | 0 | - | - | Restricted Stock Unit | |
Steven C. Gilman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 3,200 | 11,000 (0%) | 0% | - | Common Stock | |
Steven C. Gilman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 3,200 | 3,200 | - | - | Restricted Stock Unit | |
Steven C. Gilman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 8,000 | 8,000 | - | - | Stock Option (Right to Buy) | |
Steven C. Gilman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 3,200 | 0 | - | - | Restricted Stock Unit | |
Alan L. Rubino | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 3,200 | 23,794 (0%) | 0% | - | Common Stock | |
Alan L. Rubino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 3,200 | 3,200 | - | - | Restricted Stock Unit | |
Alan L. Rubino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 8,000 | 8,000 | - | - | Stock Option (Right to Buy) | |
Alan L. Rubino | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 3,200 | 0 | - | - | Restricted Stock Unit | |
Kevin F. Mclaughlin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 3,200 | 11,900 (0%) | 0% | - | Common Stock | |
Kevin F. Mclaughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 3,200 | 3,200 | - | - | Restricted Stock Unit | |
Kevin F. Mclaughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 8,000 | 8,000 | - | - | Stock Option (Right to Buy) | |
Kevin F. Mclaughlin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 3,200 | 0 | - | - | Restricted Stock Unit | |
Heidi M. Hagen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 8,000 | 8,000 | - | - | Stock Option (Right to Buy) | |
Heidi M. Hagen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 3,200 | 3,200 | - | - | Restricted Stock Unit | |
Heidi M. Hagen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 3,200 | 0 | - | - | Restricted Stock Unit | |
Heidi M. Hagen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 3,200 | 18,650 (0%) | 0% | - | Common Stock | |
Lisa Wright | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 8,000 | 8,000 | - | - | Stock Option (Right to Buy) | |
Lisa Wright | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 3,200 | 0 | - | - | Restricted Stock Unit | |
Lisa Wright | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 3,200 | 9,017 (0%) | 0% | - | Common Stock | |
Lisa Wright | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 3,200 | 3,200 | - | - | Restricted Stock Unit | |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.20 per share. | 30 Apr 2024 | 13,888 | 209,195 (0%) | 0% | 7.2 | 99,994 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2024 | 5,555 | 219,445 | - | - | Stock Option (Right to Buy) | |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2024 | 6,002 | 303,998 | - | - | Stock Option (Right to Buy) | |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2024 | 13,888 | 279,307 | - | - | Stock Option (Right to Buy) | |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.00 per share. | 30 Apr 2024 | 5,555 | 220,752 (0%) | 0% | 18 | 99,990 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.66 per share. | 30 Apr 2024 | 6,002 | 215,197 (0%) | 0% | 16.7 | 99,993 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2024 | 17,500 | 262,500 | - | - | Stock Option (Right to Buy) | |
Dominick C. Colangelo | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 44.59 per share. | 17 Apr 2024 | 17,500 | 195,307 (0%) | 0% | 44.6 | 780,325 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2024 | 17,500 | 245,000 | - | - | Stock Option (Right to Buy) | |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.02 per share. | 17 Apr 2024 | 17,500 | 212,807 (0%) | 0% | 3.0 | 52,850 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 46.47 per share. | 17 Apr 2024 | 17,500 | 195,307 (0%) | 0% | 46.5 | 813,225 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.02 per share. | 17 Apr 2024 | 17,500 | 212,807 (0%) | 0% | 3.0 | 52,850 | Common Stock |
Alan L. Rubino | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 09 Apr 2024 | 3,000 | 20,594 (0%) | 0% | 4.1 | 12,360 | Common Stock |
Alan L. Rubino | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2024 | 3,000 | 0 | - | - | Stock Option (Right to Buy) | |
Robert L. Zerbe | Director | Sale of securities on an exchange or to another person at price $ 51.57 per share. | 27 Mar 2024 | 3,278 | 23,395 (0%) | 0% | 51.6 | 169,046 | Common Stock |
Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2024 | 3,278 | 0 | - | - | Stock Option (Right to Buy) | |
Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.74 per share. | 27 Mar 2024 | 3,278 | 26,673 (0%) | 0% | 3.7 | 12,260 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 44.67 per share. | 13 Mar 2024 | 17,500 | 194,870 (0%) | 0% | 44.7 | 781,725 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.02 per share. | 13 Mar 2024 | 17,500 | 212,370 (0%) | 0% | 3.0 | 52,850 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2024 | 17,500 | 280,000 | - | - | Stock Option (Right to Buy) | |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2024 | 17,500 | 297,500 | - | - | Stock Option (Right to Buy) | |
Dominick C. Colangelo | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 44.02 per share. | 13 Mar 2024 | 17,500 | 194,870 (0%) | 0% | 44.0 | 770,350 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.02 per share. | 13 Mar 2024 | 17,500 | 212,370 (0%) | 0% | 3.0 | 52,850 | Common Stock |
Michael Halpin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 44.71 per share. | 11 Mar 2024 | 7,874 | 949 (0%) | 0% | 44.7 | 352,047 | Common Stock |
Sean C. Flynn | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 45.33 per share. | 08 Mar 2024 | 8,115 | 167 (0%) | 0% | 45.3 | 367,853 | Common Stock |
Sean C. Flynn | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 45.33 per share. | 08 Mar 2024 | 8,115 | 167 (0%) | 0% | 45.3 | 367,853 | Common Stock |
Jonathan Siegal | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 45.00 per share. | 07 Mar 2024 | 1,634 | 1,400 (0%) | 0% | 45 | 73,530 | Common Stock |
Flynn C. Sean | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 12,000 | 12,000 | - | - | Restricted Stock Unit | |
Mara Joseph A. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 46,250 | 46,250 | - | - | Stock Option (Right to Buy) | |
Flynn C. Sean | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
Mark Hopper Jonathan | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 12,000 | 12,000 | - | - | Restricted Stock Unit | |
Mark Jonathan Hopper | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
Michael Halpin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 21,000 | 21,000 | - | - | Restricted Stock Unit | |
C. Colangelo Dominick | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 182,500 | 182,500 | - | - | Stock Option (Right to Buy) | |
Joseph A. Mara | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 18,500 | 18,500 | - | - | Restricted Stock Unit | |
Jonathan Siegal | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 7,500 | 7,500 | - | - | Restricted Stock Unit | |
Colangelo Dominick C. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 73,000 | 73,000 | - | - | Restricted Stock Unit | |
Jonathan Siegal | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 7,500 | 7,500 | - | - | Stock Option (Right to Buy) | |
Michael Halpin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 52,500 | 52,500 | - | - | Stock Option (Right to Buy) | |
Zerbe L. Robert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.74 per share. | 20 Feb 2024 | 722 | 24,117 (0%) | 0% | 3.7 | 2,700 | Common Stock |
Flynn Sean C. | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 3,000 | 9,000 | - | - | Restricted Stock Unit | |
Hopper Mark Jonathan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 1,750 | 58,695 (0%) | 0% | 0 | Common Stock | |
Flynn C. Sean | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 2,325 | 8,341 (0%) | 0% | 0 | Common Stock | |
Jonathan Hopper Mark | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.50 per share. | 20 Feb 2024 | 1,379 | 55,605 (0%) | 0% | 49.5 | 68,261 | Common Stock |
Halpin Michael | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 2,812 | 10,155 (0%) | 0% | 0 | Common Stock | |
Halpin Michael | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 5,250 | 7,917 (0%) | 0% | 0 | Common Stock | |
Michael Halpin | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.50 per share. | 20 Feb 2024 | 2,587 | 5,330 (0%) | 0% | 49.5 | 128,057 | Common Stock |
Jonathan Siegal | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 2,500 | 7,500 | - | - | Restricted Stock Unit | |
Siegal Jonathan | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.50 per share. | 20 Feb 2024 | 169 | 3,034 (0%) | 0% | 49.5 | 8,366 | Common Stock |
Flynn Sean C. | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.50 per share. | 20 Feb 2024 | 1,441 | 6,016 (0%) | 0% | 49.5 | 71,330 | Common Stock |
Jonathan Hopper Mark | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 3,000 | 56,984 (0%) | 0% | 0 | Common Stock | |
A. Joseph Mara | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.50 per share. | 20 Feb 2024 | 1,459 | 17,342 (0%) | 0% | 49.5 | 72,221 | Common Stock |
Siegal Jonathan | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 420 | 3,203 (0%) | 0% | 0 | Common Stock | |
Zerbe L. Robert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 722 | 3,278 | - | - | Stock Option (Right to Buy) | |
Flynn C. Sean | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 1,750 | 1,750 | - | - | Restricted Stock Unit | |
Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 3,000 | 9,000 | - | - | Restricted Stock Unit | |
C. Sean Flynn | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 1,750 | 9,059 (0%) | 0% | 0 | Common Stock | |
Michael Halpin | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.50 per share. | 20 Feb 2024 | 1,332 | 8,823 (0%) | 0% | 49.5 | 65,934 | Common Stock |
Robert Zerbe L. | Director | Sale of securities on an exchange or to another person at price $ 50.01 per share. | 20 Feb 2024 | 722 | 23,395 (0%) | 0% | 50.0 | 36,107 | Common Stock |
Jonathan Siegal | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 420 | 840 | - | - | Restricted Stock Unit | |
C. Flynn Sean | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.50 per share. | 20 Feb 2024 | 1,032 | 7,309 (0%) | 0% | 49.5 | 51,084 | Common Stock |
Jonathan Siegal | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 2,500 | 3,900 (0%) | 0% | 0 | Common Stock | |
Jonathan Hopper Mark | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 2,325 | 57,930 (0%) | 0% | 0 | Common Stock | |
Dominick Colangelo C. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 11,700 | 23,400 | - | - | Restricted Stock Unit | |
Jonathan Hopper Mark | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 1,750 | 1,750 | - | - | Restricted Stock Unit | |
Mara A. Joseph | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.50 per share. | 20 Feb 2024 | 809 | 19,288 (0%) | 0% | 49.5 | 40,046 | Common Stock |
A. Joseph Mara | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 2,755 | 5,509 | - | - | Restricted Stock Unit | |
Jonathan Siegal | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.50 per share. | 20 Feb 2024 | 1,117 | 2,783 (0%) | 0% | 49.5 | 55,292 | Common Stock |
Halpin Michael | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 3,825 | 9,155 (0%) | 0% | 0 | Common Stock | |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 18,250 | 192,258 (0%) | 0% | 0 | Common Stock | |
Halpin Michael | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.50 per share. | 20 Feb 2024 | 1,812 | 7,343 (0%) | 0% | 49.5 | 89,694 | Common Stock |
Colangelo Dominick C. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 18,250 | 54,750 | - | - | Restricted Stock Unit | |
C. Colangelo Dominick | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 8,937 | 8,938 | - | - | Restricted Stock Unit | |
Mark Hopper Jonathan | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.50 per share. | 20 Feb 2024 | 742 | 57,953 (0%) | 0% | 49.5 | 36,729 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 11,700 | 195,499 (0%) | 0% | 0 | Common Stock | |
Colangelo C. Dominick | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.50 per share. | 20 Feb 2024 | 5,423 | 190,076 (0%) | 0% | 49.5 | 268,439 | Common Stock |
Jonathan Hopper Mark | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 2,325 | 4,650 | - | - | Restricted Stock Unit | |
C. Flynn Sean | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.50 per share. | 20 Feb 2024 | 777 | 8,282 (0%) | 0% | 49.5 | 38,462 | Common Stock |
Colangelo C. Dominick | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 8,937 | 199,013 (0%) | 0% | 0 | Common Stock | |
A. Mara Joseph | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 2,755 | 20,097 (0%) | 0% | 0 | Common Stock | |
Colangelo C. Dominick | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.50 per share. | 20 Feb 2024 | 4,143 | 194,870 (0%) | 0% | 49.5 | 205,079 | Common Stock |
Mark Hopper Jonathan | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.50 per share. | 20 Feb 2024 | 985 | 56,945 (0%) | 0% | 49.5 | 48,758 | Common Stock |
Sean Flynn C. | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 3,000 | 7,457 (0%) | 0% | 0 | Common Stock | |
Joseph A. Mara | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 4,625 | 18,801 (0%) | 0% | 0 | Common Stock | |
Mara A. Joseph | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 4,625 | 13,875 | - | - | Restricted Stock Unit | |
Halpin Michael | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 5,250 | 15,750 | - | - | Restricted Stock Unit | |
C. Colangelo Dominick | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.50 per share. | 20 Feb 2024 | 8,459 | 183,799 (0%) | 0% | 49.5 | 418,721 | Common Stock |
Michael Halpin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 2,812 | 2,813 | - | - | Restricted Stock Unit | |
Flynn Sean C. | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 2,325 | 4,650 | - | - | Restricted Stock Unit | |
Halpin Michael | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 3,825 | 7,650 | - | - | Restricted Stock Unit | |
Colangelo C. Dominick | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 48.85 per share. | 14 Feb 2024 | 17,500 | 174,008 (0%) | 0% | 48.9 | 854,875 | Common Stock |
C. Colangelo Dominick | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.02 per share. | 14 Feb 2024 | 17,500 | 191,508 (0%) | 0% | 3.0 | 52,850 | Common Stock |
C. Colangelo Dominick | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 17,500 | 332,500 | - | - | Stock Option (Right to Buy) | |
Colangelo C. Dominick | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.02 per share. | 14 Feb 2024 | 17,500 | 191,508 (0%) | 0% | 3.0 | 52,850 | Common Stock |
Colangelo Dominick C. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 17,500 | 315,000 | - | - | Stock Option (Right to Buy) | |
C. Colangelo Dominick | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 46.99 per share. | 14 Feb 2024 | 17,500 | 174,008 (0%) | 0% | 47.0 | 822,325 | Common Stock |
Colangelo Dominick C. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2024 | 7,500 | 177,485 (0%) | 0% | 0 | Common Stock | |
Mark Jonathan Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2024 | 1,625 | 0 | - | - | Restricted Stock Unit | |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2024 | 7,500 | 0 | - | - | Restricted Stock Unit | |
Jonathan Mark Hopper | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.42 per share. | 12 Feb 2024 | 775 | 53,984 (0%) | 0% | 47.4 | 36,751 | Common Stock |
C. Colangelo Dominick | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.42 per share. | 12 Feb 2024 | 3,477 | 174,008 (0%) | 0% | 47.4 | 164,879 | Common Stock |
Halpin Michael | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2024 | 3,500 | 4,449 (0%) | 0% | 0 | Common Stock | |
Halpin Michael | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2024 | 3,500 | 0 | - | - | Restricted Stock Unit | |
Michael Halpin | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.42 per share. | 12 Feb 2024 | 1,782 | 2,667 (0%) | 0% | 47.4 | 84,502 | Common Stock |
Mark Hopper Jonathan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2024 | 1,625 | 54,759 (0%) | 0% | 0 | Common Stock | |
Zerbe Robert L. | Director | Sale of securities on an exchange or to another person at price $ 44.22 per share. | 29 Jan 2024 | 2,300 | 23,395 (0%) | 0% | 44.2 | 101,706 | Common Stock |
Zerbe Robert L. | Director | Sale of securities on an exchange or to another person at price $ 44.02 per share. | 25 Jan 2024 | 200 | 25,695 (0%) | 0% | 44.0 | 8,804 | Common Stock |
Zerbe Robert L. | Director | Sale of securities on an exchange or to another person at price $ 41.39 per share. | 22 Jan 2024 | 2,500 | 28,395 (0%) | 0% | 41.4 | 103,475 | Common Stock |
L. Zerbe Robert | Director | Sale of securities on an exchange or to another person at price $ 42.05 per share. | 22 Jan 2024 | 3,000 | 25,895 (0%) | 0% | 42.1 | 126,150 | Common Stock |
Zerbe Robert L. | Director | Sale of securities on an exchange or to another person at price $ 42.06 per share. | 22 Jan 2024 | 2,500 | 25,895 (0%) | 0% | 42.1 | 105,150 | Common Stock |
L. Robert Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2024 | 3,000 | 0 | - | - | Stock Option (Right to Buy) | |
L. Zerbe Robert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 22 Jan 2024 | 3,000 | 28,895 (0%) | 0% | 4.1 | 12,360 | Common Stock |
Dominick Colangelo C. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.02 per share. | 17 Jan 2024 | 16,726 | 186,711 (0%) | 0% | 3.0 | 50,513 | Common Stock |
C. Dominick Colangelo | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 37.97 per share. | 17 Jan 2024 | 16,726 | 169,985 (0%) | 0% | 38.0 | 635,086 | Common Stock |
Colangelo Dominick C. | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 38.58 per share. | 17 Jan 2024 | 16,726 | 169,985 (0%) | 0% | 38.6 | 645,289 | Common Stock |
C. Dominick Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.02 per share. | 17 Jan 2024 | 16,726 | 186,711 (0%) | 0% | 3.0 | 50,513 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2024 | 16,726 | 366,726 | - | - | Stock Option (Right to Buy) | |
Colangelo C. Dominick | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2024 | 16,726 | 350,000 | - | - | Stock Option (Right to Buy) | |
Zerbe L. Robert | Director | Sale of securities on an exchange or to another person at price $ 38.09 per share. | 12 Jan 2024 | 2,200 | 30,895 (0%) | 0% | 38.1 | 83,798 | Common Stock |
A. Joseph Mara | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 21.36 per share. | 31 Dec 2023 | 114 | 13,811 (0%) | 0% | 21.4 | 2,435 | Common Stock |
Joseph Mara A. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 28.49 per share. | 31 Dec 2023 | 90 | 13,988 (0%) | 0% | 28.5 | 2,564 | Common Stock |
Joseph A. Mara | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 28.21 per share. | 31 Dec 2023 | 78 | 14,066 (0%) | 0% | 28.2 | 2,200 | Common Stock |
Siegal Jonathan | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 28.21 per share. | 31 Dec 2023 | 95 | 1,400 (0%) | 0% | 28.2 | 2,680 | Common Stock |
Joseph Mara A. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 25.02 per share. | 31 Dec 2023 | 88 | 13,899 (0%) | 0% | 25.0 | 2,202 | Common Stock |
K. Wotton Paul | Director | Sale of securities on an exchange or to another person at price $ 37.31 per share. | 14 Dec 2023 | 5,000 | 26,802 (0%) | 0% | 37.3 | 186,550 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2023 | 12,000 | 0 | - | - | Stock Option (Right to Buy) | |
C. Colangelo Dominick | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 34.03 per share. | 13 Dec 2023 | 12,000 | 169,985 (0%) | 0% | 34.0 | 408,360 | Common Stock |
C. Sean Flynn | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 37.45 per share. | 13 Dec 2023 | 106 | 4,467 (0%) | 0% | 37.5 | 3,970 | Common Stock |
C. Dominick Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2023 | 12,000 | 12,000 | - | - | Stock Option (Right to Buy) | |
C. Dominick Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.57 per share. | 13 Dec 2023 | 12,000 | 181,985 (0%) | 0% | 3.6 | 42,840 | Common Stock |
C. Colangelo Dominick | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Dec 2023 | 6,757 | 169,985 (0%) | 0% | 0 | Common Stock | |
C. Sean Flynn | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 34.20 per share. | 13 Dec 2023 | 1,432 | 4,573 (0%) | 0% | 34.2 | 48,974 | Common Stock |
Dominick Colangelo C. | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 37.12 per share. | 13 Dec 2023 | 12,000 | 169,985 (0%) | 0% | 37.1 | 445,440 | Common Stock |
Dominick Colangelo C. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.57 per share. | 13 Dec 2023 | 12,000 | 181,985 (0%) | 0% | 3.6 | 42,840 | Common Stock |
Dominick Colangelo C. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2023 | 12,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
Dominick Colangelo C. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.57 per share. | 06 Dec 2023 | 12,397 | 189,139 (0%) | 0% | 3.6 | 44,257 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2023 | 12,397 | 36,000 | - | - | Stock Option (Right to Buy) | |
Dominick Colangelo C. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.57 per share. | 06 Dec 2023 | 12,000 | 188,742 (0%) | 0% | 3.6 | 42,840 | Common Stock |
C. Dominick Colangelo | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 34.43 per share. | 06 Dec 2023 | 12,397 | 176,742 (0%) | 0% | 34.4 | 426,829 | Common Stock |
Colangelo Dominick C. | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 33.84 per share. | 06 Dec 2023 | 12,000 | 176,742 (0%) | 0% | 33.8 | 406,080 | Common Stock |
Michael Halpin | Chief Operating Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Aug 2023 | 16,359 | 16,359 (0%) | 0% | 0 | Common Stock | |
Michael Halpin | Chief Operating Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Aug 2023 | 16,359 | 684 (0%) | 0% | 0 | Common Stock | |
Robert L. Zerbe | Director | Sale of securities on an exchange or to another person at price $ 38.84 per share. | 14 Jul 2023 | 1,000 | 33,395 (0%) | 0% | 38.8 | 38,840 | Common Stock |
Robert L. Zerbe | Director | Sale of securities on an exchange or to another person at price $ 36.00 per share. | 22 Jun 2023 | 3,000 | 34,395 (0%) | 0% | 36 | 108,000 | Common Stock |
Lisa Wright | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 433 | 434 | - | - | Restricted Stock Unit | |
Lisa Wright | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 433 | 5,817 (0%) | 0% | - | Common Stock | |
Paul K. Wotton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 8,000 | 8,000 | - | - | Stock Option (right to buy) | |
Paul K. Wotton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 3,200 | 3,200 | - | - | Restricted Stock Unit | |
Robert L. Zerbe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 8,000 | 8,000 | - | - | Stock Option (right to buy) | |
Robert L. Zerbe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 3,200 | 3,200 | - | - | Restricted Stock Unit | |
Steven C. Gilman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 8,000 | 8,000 | - | - | Stock Option (right to buy) | |
Steven C. Gilman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 3,200 | 3,200 | - | - | Restricted Stock Unit | |
Alan L. Rubino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 3,200 | 3,200 | - | - | Restricted Stock Unit | |
Alan L. Rubino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 8,000 | 8,000 | - | - | Stock Option (right to buy) | |
Kevin F. Mclaughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 8,000 | 8,000 | - | - | Stock Option (right to buy) | |
Kevin F. Mclaughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 3,200 | 3,200 | - | - | Restricted Stock Unit | |
Heidi M. Hagen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 3,200 | 3,200 | - | - | Restricted Stock Unit | |
Heidi M. Hagen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 8,000 | 8,000 | - | - | Stock Option (right to buy) | |
Lisa Wright | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 3,200 | 3,200 | - | - | Restricted Stock Unit | |
Lisa Wright | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 8,000 | 8,000 | - | - | Stock Option (right to buy) | |
Paul K. Wotton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2023 | 2,600 | 0 | - | - | Restricted Stock Unit | |
Paul K. Wotton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2023 | 2,600 | 31,802 (0%) | 0% | - | Common Stock | |
Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2023 | 2,600 | 37,395 (0%) | 0% | - | Common Stock | |
Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2023 | 2,600 | 0 | - | - | Restricted Stock Unit | |
Steven C. Gilman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2023 | 2,600 | 0 | - | - | Restricted Stock Unit | |
Steven C. Gilman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2023 | 2,600 | 7,800 (0%) | 0% | - | Common Stock | |
Alan L. Rubino | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2023 | 2,600 | 17,594 (0%) | 0% | - | Common Stock | |
Alan L. Rubino | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2023 | 2,600 | 0 | - | - | Restricted Stock Unit | |
Kevin F. Mclaughlin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2023 | 2,600 | 0 | - | - | Restricted Stock Unit | |
Kevin F. Mclaughlin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2023 | 2,600 | 8,700 (0%) | 0% | - | Common Stock | |
Heidi M. Hagen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2023 | 2,600 | 15,450 (0%) | 0% | - | Common Stock | |
Heidi M. Hagen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2023 | 2,600 | 0 | - | - | Restricted Stock Unit | |
Lisa Wright | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2023 | 2,600 | 5,384 (0%) | 0% | - | Common Stock | |
Lisa Wright | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2023 | 2,600 | 0 | - | - | Restricted Stock Unit | |
Alan L. Rubino | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2023 | 3,000 | 0 | - | - | Stock Option (Right to Buy) | |
Alan L. Rubino | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.60 per share. | 25 Apr 2023 | 3,000 | 14,994 (0%) | 0% | 10.6 | 31,800 | Common Stock |
Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 3,000 | 0 | - | - | Stock Option (Right to Buy) | |
Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.60 per share. | 01 Mar 2023 | 3,000 | 34,795 (0%) | 0% | 10.6 | 31,800 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 8,938 | 179,951 (0%) | 0% | 0 | Common Stock | |
Dominick C. Colangelo | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.82 per share. | 17 Feb 2023 | 4,143 | 175,808 (0%) | 0% | 29.8 | 123,544 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 11,700 | 176,436 (0%) | 0% | 0 | Common Stock | |
Dominick C. Colangelo | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.82 per share. | 17 Feb 2023 | 5,423 | 171,013 (0%) | 0% | 29.8 | 161,714 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 8,938 | 17,875 | - | - | Restricted Stock Unit | |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 11,700 | 35,100 | - | - | Restricted Stock Unit | |
Dominick C. Colangelo | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 179,147 | 179,147 | - | - | Stock Option (Right to Buy) | |
Dominick C. Colangelo | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 3,353 | 3,353 | - | - | Stock Option (Right to Buy) | |
Dominick C. Colangelo | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 73,000 | 73,000 | - | - | Restricted Stock Unit | |
Jonathan Mark Hopper | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.82 per share. | 17 Feb 2023 | 1,108 | 51,414 (0%) | 0% | 29.8 | 33,041 | Common Stock |
Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 1,750 | 53,164 (0%) | 0% | 0 | Common Stock | |
Jonathan Mark Hopper | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.82 per share. | 17 Feb 2023 | 752 | 52,412 (0%) | 0% | 29.8 | 22,425 | Common Stock |
Jonathan Mark Hopper | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 1,875 | 1,875 | - | - | Stock Option (Right to Buy) | |
Jonathan Mark Hopper | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 28,125 | 28,125 | - | - | Stock Option (Right to Buy) | |
Jonathan Mark Hopper | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 12,000 | 12,000 | - | - | Restricted Stock Unit | |
Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 2,325 | 6,975 | - | - | Restricted Stock Unit | |
Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 1,750 | 3,500 | - | - | Restricted Stock Unit | |
Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 2,325 | 52,522 (0%) | 0% | 0 | Common Stock | |
Michael Halpin | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.82 per share. | 17 Feb 2023 | 1,332 | 14,764 (0%) | 0% | 29.8 | 39,720 | Common Stock |
Michael Halpin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 3,825 | 18,589 (0%) | 0% | 0 | Common Stock | |
Michael Halpin | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.82 per share. | 17 Feb 2023 | 1,868 | 16,721 (0%) | 0% | 29.8 | 55,704 | Common Stock |
Michael Halpin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 3,282 | 3,282 | - | - | Stock Option (Right to Buy) | |
Michael Halpin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 49,218 | 49,218 | - | - | Stock Option (Right to Buy) | |
Michael Halpin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 21,000 | 21,000 | - | - | Restricted Stock Unit | |
Michael Halpin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 2,813 | 12,487 | - | - | Restricted Stock Unit | |
Michael Halpin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 3,825 | 4,613 | - | - | Restricted Stock Unit | |
Michael Halpin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 2,813 | 16,096 (0%) | 0% | 0 | Common Stock | |
Sean C. Flynn | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 1,875 | 1,875 | - | - | Stock Option (Right to Buy) | |
Sean C. Flynn | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 12,000 | 12,000 | - | - | Restricted Stock Unit | |
Sean C. Flynn | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 2,325 | 6,975 | - | - | Restricted Stock Unit | |
Sean C. Flynn | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 1,750 | 3,500 | - | - | Restricted Stock Unit | |
Sean C. Flynn | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.82 per share. | 17 Feb 2023 | 832 | 6,176 (0%) | 0% | 29.8 | 24,810 | Common Stock |
Sean C. Flynn | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 1,750 | 7,008 (0%) | 0% | 0 | Common Stock | |
Sean C. Flynn | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.82 per share. | 17 Feb 2023 | 1,155 | 5,258 (0%) | 0% | 29.8 | 34,442 | Common Stock |
Sean C. Flynn | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 2,325 | 6,413 (0%) | 0% | 0 | Common Stock | |
Sean C. Flynn | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 28,125 | 28,125 | - | - | Stock Option (Right to Buy) | |
Joseph A. Mara | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.82 per share. | 17 Feb 2023 | 1,065 | 13,697 (0%) | 0% | 29.8 | 31,758 | Common Stock |
Joseph A. Mara | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 2,754 | 14,762 (0%) | 0% | 0 | Common Stock | |
Joseph A. Mara | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 2,891 | 2,891 | - | - | Stock Option (Right to Buy) | |
Joseph A. Mara | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 43,359 | 43,359 | - | - | Stock Option (Right to Buy) | |
Joseph A. Mara | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 18,500 | 18,500 | - | - | Restricted Stock Unit | |
Joseph A. Mara | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 2,754 | 8,264 | - | - | Restricted Stock Unit | |
Jonathan Siegal | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 419 | 1,260 | - | - | Restricted Stock Unit | |
Jonathan Siegal | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 10,000 | 10,000 | - | - | Restricted Stock Unit | |
Jonathan Siegal | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 6,187 | 6,187 | - | - | Stock Option (Right to Buy) | |
Jonathan Siegal | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 2,813 | 2,813 | - | - | Stock Option (Right to Buy) | |
Jonathan Siegal | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.82 per share. | 17 Feb 2023 | 162 | 932 (0%) | 0% | 29.8 | 4,831 | Common Stock |
Jonathan Siegal | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 419 | 1,094 (0%) | 0% | 0 | Common Stock | |
Dominick C. Colangelo | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.30 per share. | 11 Feb 2023 | 3,515 | 164,736 (0%) | 0% | 29.3 | 102,990 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 7,500 | 7,500 | - | - | Restricted Stock Unit | |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 7,500 | 168,251 (0%) | 0% | 0 | Common Stock | |
Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 1,625 | 51,037 (0%) | 0% | 0 | Common Stock | |
Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 1,625 | 1,625 | - | - | Restricted Stock Unit | |
Jonathan Mark Hopper | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.30 per share. | 11 Feb 2023 | 840 | 50,197 (0%) | 0% | 29.3 | 24,612 | Common Stock |
Michael Halpin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 3,500 | 15,266 (0%) | 0% | 0 | Common Stock | |
Michael Halpin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 3,500 | 3,500 | - | - | Restricted Stock Unit | |
Michael Halpin | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.30 per share. | 11 Feb 2023 | 1,983 | 13,283 (0%) | 0% | 29.3 | 58,102 | Common Stock |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 6,938 | 164,004 (0%) | 0% | 0 | Common Stock | |
Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 6,938 | 0 | - | - | Restricted Stock Unit |